Ghassemian, A., Park, J. J., Tsoulis, M. W., & Kim, H. (2021). Targeting the IL-5 pathway in eosinophilic asthma: A comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts. Allergy Asthma Clin Immunol.
Citación estilo ChicagoGhassemian, Arian, Jane Jiyoon Park, Michael W. Tsoulis, y Harold Kim. "Targeting the IL-5 Pathway in Eosinophilic Asthma: A Comparison of Mepolizumab to Benralizumab in the Reduction of Peripheral Eosinophil Counts." Allergy Asthma Clin Immunol 2021.
Cita MLAGhassemian, Arian, Jane Jiyoon Park, Michael W. Tsoulis, y Harold Kim. "Targeting the IL-5 Pathway in Eosinophilic Asthma: A Comparison of Mepolizumab to Benralizumab in the Reduction of Peripheral Eosinophil Counts." Allergy Asthma Clin Immunol 2021.